How the end of a Medicare drug subsidy program could affect your costs

An AARP study reveals that the prices for the top 25 Medicare Part D drugs have nearly doubled. This significant increase in costs highlights the potential financial impact on beneficiaries as a specific Medicare drug subsidy program comes to an end. The findings emphasize the rising burden of medication expenses for seniors, as the expiration of these subsidies may lead to higher out-of-pocket costs for essential prescriptions across the Medicare Part D landscape.